Cutler Group LP I Bio, Inc. Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$0.23 - $160.0 $276 - $192,000	-1,200 Reduced 25.0%	3,600 $0
Q1 2022 Apr 14, 2022	BUY	$0.3 - $0.61 $600 - $1,220	2,000 Added 71.43%	4,800 $2,000
Q4 2021 Jan 18, 2022	SELL	$0.55 - $1.04 $3,465 - $6,552	-6,300 Reduced 69.23%	2,800 $1,000
Q3 2021 Oct 26, 2021	BUY	$1.06 - $1.52 $6,678 - $9,576	6,300 Added 225.0%	9,100 $9,000
Q1 2021 Apr 26, 2021	SELL	$1.18 - $2.62 $1,416 - $3,144	-1,200 Reduced 30.0%	2,800 $4,000
Q4 2020 Jan 21, 2021	BUY	$1.05 - $2.24 $1,365 - $2,912	1,300 Added 48.15%	4,000 $4,000
Q3 2020 Oct 27, 2020	BUY	$1.7 - $6.41 $4,590 - $17,307	2,700 New	2,700 $5,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.